Clavel-Chapelon F, Paoletti C, Benhamou S. Smoking cessation rates 4 years after treatment by nicotine gum and acupuncture. Preventive Medicine 1997;26(1):25-8.
Clavel F, Benhamou S, Company-Huertas A. Helping people to stop smoking: Randomized comparison of groups being treated with acupuncture and nicotine gum with control group. Br Med J 1985;291(6508):1538-9.
Cottraux JA, Harf R, Boissel JP, Schbath J, Bouvard M, Gillet J. Smoking cessation with behaviour therapy or acupuncture—A controlled study. Behav Res Ther 1983;21(4):417-24.
Lamontagne Y, Annable L, Gagnon MA. Acupuncture for smokers: Lack of long-term therapeutic effect in a controlled study. Can Med Assoc J 1980;122(7):787-90.
White AR, Resch KL, Ernst E. Randomized trial of acupuncture for nicotine withdrawal symptoms. Archives of Internal Medicine 1998;158(20):2251-5.
Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC et al. A comparison of sustained-release bupropion and placebo for smoking cessation [see comments]. New England Journal of Medicine 1997;337(17):1195-1202.
Jorenby DE, Leischow S, Nides M, Rennard S, Johnston JA, Hughes AR et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine 1999;340(9):685-91.
Areechon W, Punnotok J. Smoking cessation through the use of nicotine chewing gum: A double-blind trial in Thailand. Clin Ther 1988;10(2):183-6.
British Thoracic Society. Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Br Med J 1983;286(6366):595-7.
Clavel-Chapelon F, Paoletti C, Benhamou S. Smoking cessation rates 4 years after treatment by nicotine gum and acupuncture. Preventive Medicine 1997;26(1):25-8.
Fee WM, Stewart MJ. A controlled trial of nicotine chewing gum in a smoking withdrawal clinic. Practitioner 1982;226(1363):148,151.
Fortmann SP, Killen JD, Telch MJ, Newman B. Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: Initial results of the Stanford Stop Smoking Project. JAMA 1988;260(11):1575-80.
Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones RT, et al. Nicotine gum and behavioral treatment: A placebo controlled trial. J Consult Clin Psychol 1987;55(4):603-5.
Hall SM, Munoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. Journal of Consulting & Clinical Psychology 1996;64(5):1003-9.
Herrera N, Franco R, Herrera L, Partidas A, Rolando R, Fagerstrom KO. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995;108(2):447-51.
Jarvis MJ, Raw M, Russell MA, Feyerabend C. Randomised controlled trial of nicotine chewing-gum. Br Med J 1982;285(6341):537-40.
Jensen EJ, Schmidt E, Pedersen B, Dahl R. The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence. Int J Addict 1991;26(11):1223-31.
Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990;58(1):85-92.
* Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliott ML, Schweiger A. Nicotine gum in smoking cessation: A placebo-controlled, double-blind trial. Addict Behav 1983;8(3):253-61.
Table 27. Meta-Analysis: Efficacy of and estimated abstinence rates for nicotine inhaler (n=4 studies)
Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O. The nicotine inhaler in smoking cessation. Archives of Internal Medicine 1997;157(15):1721-8.
Leischow S, Nilsson F, Franzon M, Hill A, Otte PS, Merikle E. Efficacy of the nicotine inhaler as an adjunct to smoking cessation. American Journal of Health Behavior 1996;20(5):364-71.
Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 1996;91(9):1293-1306.
Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation [see comments]. JAMA 1993;269(10):1268-71.
Blondal T, Franzon M, Westin A. A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. European Respiratory Journal 1997;10(7):1585-90.
Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995;90(12):1671-82.
Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek PBM, Feyerabend C. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340(8815):324-9.
Abelin T, Ehrsam R, Buhler-Reichert A, Imhof PR, Muller P, Thommen A et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol 1989;11(3):205-14.
Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989;1(8628):7-10.
Ahluwalia JS, McNagny SE, Clark WS. Smoking cessation among inner-city African Americans using the nicotine transdermal patch [see comments]. J Gen Intern Med 1998;13(1):1-8.
Campbell IA, Prescott RJ, Tjeder-Burton SM. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med 1996;90(1):47-51.
Daughton D, Susman J, Sitorius M, Belenky S, Millatmal T, Nowak R et al. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group. Arch Fam Med 1998;7(5):425-30.
Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med 1998;7(6):569-74.
* Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest 1994;105(2):524-33.
Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ 1995;311(7001):363-6.
Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA 1994;271(8):595-600.
Jorenby DE, Leischow S, Nides M, Rennard S, Johnston JA, Hughes AR et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine 1999;340(9):685-91.
Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine 1996;335(24):1792-8.
Killen JD, Fortmann SP, Davis L, Varady A. Nicotine patch and self-help video for cigarette smoking cessation. Journal of Consulting & Clinical Psychology 1997;65(4):663-72.
Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Preventive Medicine 1995;24(1):41-7.
Lewis SF, Piasecki TM, Fiore MC, Anderson JE, Baker TB. Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Preventive Medicine 1998;27(2):296-303.
Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L et al. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch [see comments]. European Respiratory Journal 1996;9(4):643-51.
Perng RP, Hsieh WC, Chen YM, Lu CC, Chiang SJ. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. Journal of the Formosan Medical Association 1998;97(8):547-51.
Richmond RL, Kehoe L, de Almeida N. Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: one year outcome. Addiction 1997;92(1):27-31.
Russell MA, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U et al. Targeting heavy smokers in general practice: Randomised controlled trial of transdermal nicotine patches. BMJ 1993;306(6888):1308-12.
Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling [published erratum appears in Arch Intern Med 1993 Oct 25;153(20):2321]. Arch Intern Med 1993;153(16):1881-90.
* Sonderskov J, Olsen J, Sabroe S, Meillier L, Overvad K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. American Journal of Epidemiology 1997;145(4):309-18.
Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995;90(1):31-42.
Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. (see comments). N Engl J Med 1991;325(5):311-5.
Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. European Respiratory Journal 1999;13:238-46.
Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 1991;266(22):3133-8.
Westman EC, Levin ED, Rose JE. The nicotine patch in smoking cessation. A randomized trial with telephone counseling. Arch Intern Med 1993;153(16):1917-23.
Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB et al. Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomized trial. JAMA 1988;259(19):2863-6.
Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993;54(6):670-9.
Hilleman DE, Mohiuddin SM, Delcore MG, Lucas BD, Jr. Randomized, controlled trial of transdermal clonidine for smoking cessation. Ann Pharmacother 1993;27(9):1025-8.
Niaura R, Brown RA, Goldstein MG, Murphy JK, Abrams DB. Transdermal clonidine for smoking cessation: A double-blind randomized dose-response study. Experimental and Clinical Psychopharmacology 1996;4(3):285-91.
Wei H, Young D. Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms. Br J Addict 1988;83:1221-6.
Hall SM, Reus VI, Munoz RF, Sees KL, Humfleet G, Hartz DT et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking [see comments]. Archives of General Psychiatry 1998;55(8):683-90.
Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D. A randomized trial of nortriptyline for smoking cessation. Archives of Internal Medicine 1998;158(18):2035-39.
Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: Randomized trial with six year follow up. Britist Medical Journal 1999;318:285-8.
Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Preventive Medicine 1995;24(1):41-7.
Puska P, Korhonen H, Vartiainen E, Urjanheimo EL, Gustavsson G, Westin A. Combined use of nicotine patch and gum compared with gum alone i smoking cessation: a clinical trial in North Karelia. Tobacco Control 1995;4:231-5.
Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med 1998;7(6):569-74.
* Sonderskov J, Olsen J, Sabroe S, Meillier L, Overvad K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. American Journal of Epidemiology 1997;145(4):309-18.